An increasing number of billionaires are experimenting with ways to reverse aging. They take supplements, follow rigorous fitness regimens, and invest millions of dollars into research studies on anti-ageing therapies.
One entrepreneur claims he has reversed five years from his biological age by eating whole plant foods and having his team of doctors and health experts track biomarkers on him.
Bryan Johnson
Bryan Johnson is a tech millionaire who spends millions trying to reverse the aging process. He meticulously monitors every aspect of his health and follows a strict regiment of supplements, diet and exercise – not to mention undergoing numerous medical procedures, some extreme and painful.
He has assembled a team of doctors and health experts who monitor his every bodily function, using him as an experiment in promising anti-aging treatments. However, Johnson still looks around 45 or 50 years old despite his intensive regimen; nevertheless, his efforts have attracted both criticism and admiration alike; although some extravagant claims have been made, Johnson remains firm in his belief that turning back time is achievable.
As many of us have witnessed, he is all too aware of the effects that aging takes on loved ones and believes we can slow or reverse it with scientific innovations and interventions. Johnson is passionate about convening researchers from different fields to accelerate breakthrough technologies development.
His latest project involves creating an anti-aging blueprint that will assist him in reversing biological age. The blueprint will aid his decision making and ensure he stays on the right path towards reaching his goals, while also keeping health at optimal conditions through analysis of cell chemistry and metabolic processes.
His ambitious plan has already taxed him physically and mentally to its limit. Every morning before dawn he wakes up, takes two dozen supplements and medicines, drinks green juice with creatine and collagen peptides added, tracks body fat percentage fluctuations, heart rate fluctuations, blood glucose levels as well as having a machine which records how many erections occur each night and more.
He recently underwent radical anti-aging treatments by injecting his son’s plasma, with hopes that this injection could reverse the aging process and give him back his youth and body of an 18 year-old. Although this approach has garnered much media coverage, genetics and lifestyle are still key contributors in aging processes.
Mark Zuckerberg
Mark Zuckerberg is a billionaire investor who has made several investments that aim to slow or reverse aging, such as founding membership in the Longevity Fund and making donations towards various research projects on this front. He believes technology may allow humans to live up to 120 or beyond!
Zuckerberg has always been fascinated with questions surrounding life itself. Born in White Plains, New York and beginning computer programming early on. Together with Harvard roommates he founded Facebook in 2004, quickly growing it to one of the most renowned websites ever seen.
Current count for Facebook: over one billion. Users can post information about themselves such as photos, employment history and their opinions on politics or gummy bears on this platform; some information may remain private while other details only visible to friends. Zuckerberg currently runs multiple projects outside of running Facebook – his latest effort being Oculus Rift which will debut later this year.
As other tech billionaires have done, Mark Zuckerberg is investing in companies working on ways to slow or reverse aging. He has put money into Calico Labs – which studies causes of aging and creates drugs to extend lifespan – and Alphabet’s Verily Life Sciences division that develops wearable technologies that could extend lives.
Alongside his investments, Zuckerberg is also actively engaging in an anti-age regimen of his own. This involves taking metformin (a diabetes drug), exercising more, eating healthier and practicing jiu-jitsu with his group of MMA fighters who train together. His ultimate goal is to reach 125 and witness his children become successful adults while starting families of their own; as well as meeting his grandchildren!
Jeff Bezos
Jeff Bezos, Amazon founder and amateur astronaut, is fighting back against aging with pills, supplements, and intensive workout routines in his free time. Additionally, he funds research aimed at reversing it cellularly – as is now increasingly done among billionaires such as Sam Altman and Sergey Brin who use their wealth to invest in companies working towards stopping or reversing age-related illnesses.
With a net worth of $200 billion, most things seem possible. Bulking up, purchasing an unwise cowboy hat and flying to the moon are easily accomplished; but turning back time may prove more challenging; that is why so many of the world’s wealthiest entrepreneurs have invested millions into research that could prolong life on Earth.
Altos Labs is one such company. This startup employs some of the world’s best scientists in order to reprogram cells in order to extend lifespans by 50 years or more, using biotechnology that could extend telomere lengthening by reprogramming cells – with backing from major tech entrepreneurs such as Bezos reportedly having invested in Altos.
Bezos shared his insights while leading Amazon into becoming a global giant on Lex Fridman podcast recently. One key realization was that humans don’t seek truth for its own sake but instead seek status, recognition and security – with one way of accomplishing these ends being telling only half-truths about anything.”
Bezos has amassed an enormous fortune through his successful ventures as the founder and CEO of several technology startups, most notably Amazon and The Washington Post. Forbes estimates he currently holds the richest man in the world with an estimated net worth of $201 billion and recently declared his intention to focus on anti-aging research instead of CEO duties after leaving Amazon; additionally he’s an important investor in SpaceX and Blue Origin among others.
Sam Altman
Sam Altman is one of the few tech billionaires who has invested some of his own wealth into research on anti-aging. At 38 years old and worth close to $30 billion, OpenAI CEO Sam Altman is keen on exploring anti-ageing techniques. In addition, he’s put millions into a longevity startup while practicing “biohacking,” or eating healthy and exercising regularly while taking diabetes drug metformin (popular among Silicon Valley biohackers hoping to extend lifespans).
He became interested in this area of research during his time as president of Y-Combinator from 2014 to 2019. While researching experiments involving rejuvenating old mice with blood from young ones, he came across reports about rejuvenation treatments which involved young mice being fed their own blood and decided to fund startups that focused on this branch of science.
Retro Biosciences was Altman’s initial major biotech investment and is currently working to prolong human lives by replacing proteins that degrade with age. Altman invested $180 million into Retro Biosciences – one of the single-largest investments ever made by an individual into an organization seeking longevity. Retro uses prefab shipping containers as laboratories in order to complete projects more rapidly.
One former employee described Altman as an overly ambitious and divisive leader, often prioritizing his own interests over those of his teams. He would hire people he liked while firing any who didn’t fit properly – preferring those who knew or had connections to him over employees without either.
His tactics irritated some of his colleagues at the company and were reported to the board. After receiving several complaints of malfeasance or bad behavior from these colleagues, in 2021 the board took an unusually public display of discontent against him, firing him without any allegations of malfeasance or inappropriate conduct but due to him pushing the company in an unrelated direction which didn’t fit with its mission statement. He was replaced with Brad Lightcap who served on its board of directors.
